CA988523A - 1,8-naphthyridine compounds - Google Patents

1,8-naphthyridine compounds

Info

Publication number
CA988523A
CA988523A CA144,973A CA144973A CA988523A CA 988523 A CA988523 A CA 988523A CA 144973 A CA144973 A CA 144973A CA 988523 A CA988523 A CA 988523A
Authority
CA
Canada
Prior art keywords
naphthyridine compounds
naphthyridine
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA144,973A
Other languages
English (en)
Other versions
CA144973S (en
Inventor
Clarence S. Rooney
Haydn W.R. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Merck Sharp and Dohme IA Corp
Original Assignee
Laboratoires Merck Frosst
Merck Sharp and Dohme IA Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Merck Frosst, Merck Sharp and Dohme IA Corp filed Critical Laboratoires Merck Frosst
Priority to CA144,973A priority Critical patent/CA988523A/en
Priority to US00362994A priority patent/US3842087A/en
Priority to NL7307492A priority patent/NL7307492A/xx
Priority to GB2763873A priority patent/GB1395436A/en
Priority to FR7321926A priority patent/FR2189042B1/fr
Priority to DE2330554A priority patent/DE2330554A1/de
Priority to JP48067369A priority patent/JPS4949993A/ja
Priority to CH883773A priority patent/CH586222A5/xx
Application granted granted Critical
Publication of CA988523A publication Critical patent/CA988523A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA144,973A 1972-06-16 1972-06-16 1,8-naphthyridine compounds Expired CA988523A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CA144,973A CA988523A (en) 1972-06-16 1972-06-16 1,8-naphthyridine compounds
US00362994A US3842087A (en) 1972-06-16 1973-05-22 1,8-naphthyridine compounds
NL7307492A NL7307492A (el) 1972-06-16 1973-05-29
GB2763873A GB1395436A (en) 1972-06-16 1973-06-11 5,7 disubstituted 1,8 naphthyridin 2 1h-one-8
FR7321926A FR2189042B1 (el) 1972-06-16 1973-06-15
DE2330554A DE2330554A1 (de) 1972-06-16 1973-06-15 5,7-disubstituierte 1,8-naphthyridin2-on-8-oxide und verfahren zu ihrer herstellung
JP48067369A JPS4949993A (el) 1972-06-16 1973-06-16
CH883773A CH586222A5 (el) 1972-06-16 1973-06-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA144,973A CA988523A (en) 1972-06-16 1972-06-16 1,8-naphthyridine compounds

Publications (1)

Publication Number Publication Date
CA988523A true CA988523A (en) 1976-05-04

Family

ID=4093588

Family Applications (1)

Application Number Title Priority Date Filing Date
CA144,973A Expired CA988523A (en) 1972-06-16 1972-06-16 1,8-naphthyridine compounds

Country Status (8)

Country Link
US (1) US3842087A (el)
JP (1) JPS4949993A (el)
CA (1) CA988523A (el)
CH (1) CH586222A5 (el)
DE (1) DE2330554A1 (el)
FR (1) FR2189042B1 (el)
GB (1) GB1395436A (el)
NL (1) NL7307492A (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169092A (en) * 1968-02-28 1979-09-25 Bayer John W Transition metal-naphthyridine chemical complexes
US3928367A (en) * 1969-04-14 1975-12-23 Schering Corp 1-Amino naphthyridines
US3962262A (en) * 1973-04-11 1976-06-08 Merck & Co., Inc. 1,8-naphthyridine compounds
US4031103A (en) * 1974-06-07 1977-06-21 Merck Sharp & Dohme (I.A.) Corporation 1,8-Naphthyridine compounds
US4452800A (en) * 1982-04-26 1984-06-05 Schering Corporation Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases
MX2011004396A (es) * 2008-10-29 2011-05-25 Basf Se Piridinas sustituidas con accion herbicida.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH48A (fr) * 1888-11-15 1889-06-13 Gustave Falconnier Briquetages légers et économiques
US3658796A (en) * 1968-04-10 1972-04-25 Boehringer Mannheim Gmbh 5-nitrofuran derivatives

Also Published As

Publication number Publication date
JPS4949993A (el) 1974-05-15
GB1395436A (en) 1975-05-29
US3842087A (en) 1974-10-15
FR2189042A1 (el) 1974-01-25
CH586222A5 (el) 1977-03-31
NL7307492A (el) 1973-12-18
FR2189042B1 (el) 1976-10-22
DE2330554A1 (de) 1974-01-10

Similar Documents

Publication Publication Date Title
CA999860A (en) Imidazo-(1,2-a)-(benzodiazepine-1,4) compounds
CA1012534A (en) 2,6-diaminonebularine derivatives
CA966134A (en) 1,8-naphthyridine compounds
CA988522A (en) 1,8-naphthyridine compounds
CA988523A (en) 1,8-naphthyridine compounds
CA1000274A (en) Diacyl-5,6,11,12-tetrahydro-dibenzo(b,f) (1,4) diazocines
CA993452A (en) 2,6-dihalo-4-cyanophenoxy-acetonitriles
CA1009666A (en) 2,5,5-trimethyl-hepta-2,6-dienal
CA1020953A (en) 2,2,3-endo-trimethyl-7-anti-amino-norbornanes
AU472337B2 (en) 11, 12-secoprostaglandins
AU467306B2 (en) 15, 16-methylene-4-oestren-17 -ols
CA999595A (en) 3,5-dialkyl-4-hydroxybenzyl-oxiranes and -thiiranes
AU474523B2 (en) Substituted 9,10-dihydroanthracenes
AU469505B2 (en) 1,4-ethano-2,3-dihydroquinoline derivatives
CA1005443A (en) Thienodiazepine compounds
CA987669A (en) 10,11-anhydroerythromycins
CA986936A (en) 2,3,5-substituted-6-trifluoromethyl-1,3-diazin-4-ones
CA990280A (en) 5,6-trans-25-hydroxycholecalciferol
AU5701673A (en) 3, 4-dialkanyloxyphenyl)-l-alanines
AU477691B2 (en) 2, 4, 5-trisubstituted-imidazoles
CA895310A (en) 1,2,4-triazine-5-ones
CA902063A (en) 1,2,8,9-tetraazaphenalene-3-hydrazones
CA914198A (en) 1,4-disubstituted-cyclohex-3-enes
CA902042A (en) 21,21-dichlorosteroids
CA900975A (en) 8,5 - amino - substituted-tetrahydrohalo-sulfamyl-quinazolinones